CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
2.760
-0.010 (-0.36%)
Dec 20, 2024, 4:00 PM EST - Market closed

CalciMedica Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-13.59-34.36-7.82-23.5-15.18
Depreciation & Amortization
0.060.060.050.040.01
Other Amortization
----0.96
Loss (Gain) From Sale of Investments
-0.58-0.15---
Stock-Based Compensation
1.6512.041.812.110.71
Other Operating Activities
-7.01-3.06-6.41.96-0.28
Change in Accounts Payable
0.16-1.430.93-0.251.95
Change in Other Net Operating Assets
-0.481.16-0.33-0.872.15
Operating Cash Flow
-19.79-25.73-11.76-20.51-9.69
Capital Expenditures
-0.01-0.08-0-0.21-0.16
Investment in Securities
-1.938.96---
Investing Cash Flow
-1.938.88-0-0.21-0.16
Long-Term Debt Issued
--8.46-2.1
Net Debt Issued (Repaid)
--8.46-2.1
Issuance of Common Stock
19.2310.590.020.010.01
Other Financing Activities
010.31--0.77-
Financing Cash Flow
19.2320.98.4820.5514.01
Net Cash Flow
-2.494.05-3.29-0.174.16
Free Cash Flow
-19.79-25.81-11.76-20.72-9.85
Free Cash Flow Per Share
-2.10-5.75-143.00-7.63-3.74
Levered Free Cash Flow
-12.57-2.44-6.31-12.61-
Unlevered Free Cash Flow
-12.57-2.37-6.23-12.61-
Change in Net Working Capital
0.310.72-0.791.09-
Source: S&P Capital IQ. Standard template. Financial Sources.